Kindred Biosciences, Inc.
(NASDAQ : KIN)

( )
KIN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-0.21%160.912.9%$684.43m
ZTSZoetis, Inc. Class A
-0.83%126.581.9%$246.19m
MYLMylan N.V.
-0.26%19.043.2%$195.52m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-2.69%7.252.0%$166.98m
TXMDTherapeuticsMD, Inc.
0.72%2.8024.9%$10.76m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
0.43%35.202.0%$8.17m
TAROTaro Pharmaceutical Industries Ltd.
-0.24%80.556.4%$2.96m
KINKindred Biosciences, Inc.
-3.46%7.530.3%$1.57m
JAGXJaguar Animal Health, Inc.
-7.81%1.189.8%$1.45m
ABEOAbeona Therapeutics, Inc.
-7.27%2.047.6%$1.36m
LFVNLifeVantage Corporation
0.94%11.863.3%$0.90m
CPHIChina Pharma Holdings, Inc.
0.58%0.260.1%$0.04m

Company Profile

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.